Soterix Medical

Name

Soterix Medical

Legal name

Soterix Medical Inc.

Website

https://soterixmedical.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Neuromodulation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

akta.pro secondary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Neuromodulation medical devices
• Transcranial stimulation systems
• Non-invasive brain stimulation
• FDA-cleared neurotechnology
• Intraoperative neuromonitoring

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of FDA-cleared clinical devices including tDCS-LTE Depression system, PainX tDCS, SPRY TMS, MEGA-IOM, IontoDC, and accessories. One-time capital equipment purchases with supporting consumables and accessories.
2. Research Systems Sales: Sale of research-grade neuromodulation platforms (1x1 tDCS/tES, HD-tDCS, MxN systems, TMS, tFUS, multimodal solutions) to academic and clinical research institutions.
3. Software Licensing: Neurotargeting software (HD-Explore, HD-Targets) and neuronavigation systems. Modeling services for individualized treatment optimization.
4. Clinical Trial Services: Contract research services supporting clinical trials with proprietary neuromodulation technologies. Includes device provision, protocol support, and data collection.
5. Technology Distribution: Distribution of synergistic technologies including mobile EEG (SMARTING), fNIRS (NIRSIT), tFUS (BrainSonix), and neuronavigation (Brain Science Tools) through distribution partnerships.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Soterix Medical designs, manufactures, and sells non-invasive neuromodulation and brain stimulation medical devices for both clinical treatment and neuroscience research. The product portfolio includes FDA-cleared systems such as tDCS-LTE for depression, PainX tDCS and TENS for pain management, SPRY TMS for major depressive disorder, MEGA-IOM for intraoperative neuromonitoring, IontoDC for iontophoretic drug delivery, and Electro-Detox for opioid withdrawal symptom reduction. Research-grade platforms span HD-tDCS, MxN-series systems, MEGA-TMS, tFUS, Temporal Interference Stimulation, transcutaneous spinal DCS, taVNS, and Neurotargeting software (HD-Explore, HD-Targets) used by over 1,200 medical centers worldwide.

Product overview

Soterix Medical offers a comprehensive neuromodulation and brain monitoring technology platform with research and clinical product lines. The portfolio spans multiple stimulation modalities including transcranial Direct Current Stimulation (tDCS), High-Definition tES (HD-tES), Transcranial Magnetic Stimulation (TMS), Transcranial Focused Ultrasound Stimulation (tFUS), and Temporal Interference Stimulation (TI). Research systems include the 1x1 tDCS/tES Platform and HD-tDCS/HD-tES (MxN Series) for targeted brain stimulation, paired with Neurotargeting Software (HD-Explore, HD-Targets) for electrode optimization. The MxN-GO EEG enables wireless combined stimulation and recording. Mobile EEG (SMARTING) and fNIRS (NIRSIT) provide monitoring integration. Clinical products include Depression tDCS-LTE and PainX tDCS for FDA-cleared treatments, SPRY TMS for depression, and MEGA-IOM for intraoperative monitoring. The company distributes complementary technologies including Neural Navigator neuronavigation and tFUS systems through partnerships.

Differentiator

Problem solved

Functional benefit

Brands

• SPRY TMS: FDA-cleared Transcranial Magnetic Stimulation system for treatment of Major Depressive Disorder
• tDCS-LTE
• PainX
• MxN-GO EEG
• MEGA-IOM
• HD-tDCS
• IontoDC
• Electro-Detox

Products and services

• SPRY TMS FDA-cleared Transcranial Magnetic Stimulation system for Major Depressive Disorder treatment. Features rapid liquid cooling, on-device touchscreen interface, and interchangeable coil design for ergonomic and portable operation.
• MxN-GO EEG Combined wireless HD-tES and EEG system developed with mBrainTrain partnership. Features 32 recording and 33 stimulation channels with wire-free design for mobile research environments.
• MEGA-IOM FDA 510(k) cleared Intraoperative Neurophysiologic Monitoring system providing integrated control of central and peripheral nervous systems to reduce postoperative risk and improve surgical outcomes.
• 1x1 tDCS/tES Platform Industry-standard low-intensity non-invasive electrical brain stimulation platform with customizable stimulation options including tDCS, tACS, tPCS, and tRNS waveforms. Features Open-Panel controls and modular design.
• HD-tDCS/HD-tES (MxN Series) High-Definition transcranial Electrical Stimulation platforms providing targeted non-invasive neuromodulation with focal current delivery. Includes MxN-5, MxN-9, MxN-PRO systems with independent channel control up to 128 channels.
• MEGA-TMS High-power transcranial magnetic stimulation system with unmatched strength and control for advanced neuromodulation research.
• Depression tDCS-LTE System FDA-cleared clinical system for Major Depressive Disorder treatment using Limited Total Energy tDCS technology. Non-invasive in-office treatment with minimal side effects.
• PainX tDCS FDA-cleared transcranial direct current stimulation system for treatment of fibromyalgia and migraine. CE Marked for pain management applications.
• PainX TENS FDA-cleared transcutaneous electrical nerve stimulator for relief of chronic intractable pain and temporary muscle pain with widest pulse width for deeper pain relief.
• IontoDC FDA 510(k) cleared battery-operated device using weak direct current to introduce ions into the body for pharmaceutical delivery and peripheral nerve stimulation for diagnostic purposes.
• REMOTE Neuromodulation System Home-based deployed transcranial electrical stimulation platform including mini-CT device, SNAP Headgear, and ElectraRx portal for remotely supervised neuromodulation.
• SPRY POINT Neuronavigation FDA-cleared neuronavigation system for precise TMS coil positioning based on MRI. Provides accurate and precise navigation for SPRY TMS devices.
• HD-Explore Software Stand-alone tDCS, tES, HD-tDCS, and HD-tES modeling software providing brain current flow predictions with equivalent accuracy to advanced engineering software. Supports individualized modeling and integration with ROAST application.
• HD-Targets Software Revolutionary targeting software determining optimal HD electrode configuration for any brain target. Allows selection from Talairach labels, Human Connectome Project parcels, and voxel-based targeting with EEG-guided reciprocity principle.
• ElectraRx Portal Software platform connecting administrators and clinicians with stimulation data, session tracking, assessment visualization, and adaptive stimulation options.
• taVNS (Transcutaneous Auricular Vagus Nerve Stimulation) Transcutaneous auricular Vagus Nerve Stimulation system with dedicated device and accessories developed for clinical brain stimulation research. Based on mini-CT platform.
• Galvanic Vestibular Stimulation (GVS) First and only device and accessories optimized for non-invasive galvanic electrical vestibular stimulation.
• tFUS (Transcranial Focused Ultrasound Stimulation) Fully integrated transcranial Focused Ultrasound Stimulation solution developed by BrainSonix for rigorous and safe experimentation with proven placebo option using sham pads.
• Temporal Interference Stimulation (TI/IFS) Interferential and Temporal Interference Stimulation system for non-invasive deep brain stimulation. First integrated device and accessory set for clinical research on IF/TI stimulation.
• Transcutaneous Spinal DCS (tSDCS) Only system, electrodes, and accessories designed for controlled transcutaneous spinal direct current stimulation.
• NIRSIT fNIRS System Highest density functional Near Infrared Spectroscopy system in ergonomic form factor. First truly wireless system with unmatched specifications. Available in standard, LITE, and ON variants.
• SMARTING Mobile EEG Mobile EEG solutions from mBrainTrain partnership including SMARTING PRO Line, Smarting S, and Smarting Spectra. First truly mobile EEG device offering research-grade brain signals.
• Pre-Clinical Animal Systems Animal DCS/tES and Animal TMS systems optimized for pre-clinical research. Includes RK-20 Animal tFUS and Linear Current Isolator.
• Electro-Detox FDA 510(k) cleared treatment for reduction of opiate and opioid withdrawal symptoms using gentle current pulses to stimulate cranial nerve branches.

Quantifiable outcome

• In BETTER trial (Bipolar Depression Electrical Treatment Trial), tDCS-LTE demonstrated efficacy for treatment-resistant bipolar depression
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and secondary.

• Columbia UniversitycoreStrategic or Co-development Partner · 13 October 2022NIH-funded clinical trials at Columbia University for Parcel-Guided rTMS software development. Soterix Medical received Fast Track NIH grant to develop cloud-based targeting software with clinical trials at Columbia.
• mBrainTraincoreTechnology or IntegrationPartnership with mBrainTrain for mobile EEG technology. Collaboratively developed MxN-GO EEG system combining Soterix Medical's HD-tES with mBrainTrain's SMARTING mobile EEG technology. The system provides wire-free integrated stimulation and recording for research in mobile environments.
• Brain Science ToolscoreTechnology or IntegrationDistribution partnership for Neural Navigator neuronavigation system, which is FDA 510(k) cleared for accurate positioning of TMS coil based on MRI. The system is indicated for precise brain targeting in TMS treatments.
• BrainSonixsecondaryTechnology or IntegrationDistribution partnership for Transcranial Focused Ultrasound Stimulation (tFUS) system developed by BrainSonix pioneers. Provides fully integrated solution for rigorous and safe tFUS experimentation including the only proven placebo (sham pads) option in the industry.
• ElMindA Ltd.secondaryStrategic or Co-development PartnerStrategic partnership to develop new paradigm for pain control. Joint development combining ElMindA's pain network visualization technology with Soterix Medical's tDCS for targeted pain treatment. Harvard Medical School clinical trial for fibromyalgia.
• OBELABsecondaryTechnology or IntegrationIntegration partnership for NIRSIT fNIRS system and collaboration on fNIRS analysis webinars. OBELAB provides NIRSIT devices and joint educational content on functional near infrared spectroscopy applications.
• Storz MedicalsecondaryTechnology or IntegrationJoint hosting of Transcranial Pulse Stimulation (TPS) webinars with Storz Medical, developer of NEUROLITH system. TPS delivers acoustic pulses for focal brain stimulation reaching depths of 8cm.
• Artinis SystemssecondaryTechnology or IntegrationDistribution partnership for Artinis Systems fNIRS technology, integrated into Soterix Medical's multimodal solutions portfolio.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Others

• ANT Neuro: ANT Neuro is a research-grade EEG and TMS-EEG systems provider whose hardware is natively compatible with Soterix's HD-tES platforms. Acts as an enabling partner in the multimodal stimulation/recording ecosystem that Soterix integrates within its research product line.
• mBrainTrain: mBrainTrain develops the SMARTING mobile EEG system that Soterix co-developed into the MxN-GO EEG combined HD-tES/EEG product. Functions as a strategic technology partner rather than competitor, but its standalone mobile EEG products overlap in the research neuroscience market Soterix serves.
• Storz Medical (Karl Storz): Storz Medical manufactures the NEUROLITH system for Transcranial Pulse Stimulation (TPS), which delivers acoustic pulses for focal brain stimulation. Soterix is already a co-marketing partner with Storz for TPS webinars, indicating an adjacent technology partnership rather than direct competition, though both target clinical neurology and psychiatric indications.

Emerging players

• Flow Neuroscience: Flow Neuroscience developed an at-home tDCS headset for depression that achieved 58% response rate in its pivotal trial and received EU MDR/FDA pathway progress. Directly competes with Soterix's REMOTE-tDCS home depression program in the emerging at-home neuromodulation category.
• Ybrain: Ybrain is a Korean-based neuromodulation company developing wearable tDCS devices for depression and cognitive disorders. Overlaps with Soterix's portable tES and home-based REMOTE platforms, particularly across Asian clinical research markets where Soterix also holds HSA Singapore approval.

Direct peers

• MagVenture: MagVenture develops FDA-cleared TMS systems (MagPro) used in clinical depression treatment and research applications. Direct competitor in the TMS hardware market, especially for hospitals and academic medical centers that purchase both research and clinical TMS equipment.
• Neuronetics: Neuronetics markets NeuroStar, the first FDA-cleared TMS system for depression and a direct US competitor to Soterix's SPRY TMS. Both companies target treatment-resistant MDD in psychiatric and neurology clinics, competing on portability, clinic workflow, and reimbursement support.
• Brainsway: Brainsway develops deep TMS systems with FDA clearance for depression, OCD, and smoking cessation. Overlaps directly with Soterix in clinical TMS for psychiatric indications and competes for the same US clinic accounts that Soterix is targeting with SPRY TMS.
• Magstim: Magstim manufactures TMS stimulators and coils widely used in both research and clinical practice, including the Neurosoft TMS line acquired from Neurosolutions. Competes with Soterix across the MEGA-TMS/SPRY TMS product range for both research labs and clinical TMS providers.
• Neuroelectrics: Neuroelectrics provides Starstim, a wireless multichannel transcranial current stimulation (tES) system for research and clinical applications. Closest non-invasive electrical stimulation competitor to Soterix's HD-tDCS/MxN platforms, competing for neuroscience labs and clinical trials.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/soterixmedical
• YouTubeyoutube.com/channel/UCAglVs1fNouJ-Q0HMwenPVA
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/soterix-medical
• Instagraminstagram.com/soterixmedical/?hl=en

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Soterix Medical